Clinical Trial Details
| Trial ID: | L5479 |
| Source ID: | NCT02475070 |
| Associated Drug: | Vildagliptin |
| Title: | Vildagliptin Versus Dapagliflozin on Glucagon |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | YES |
| Results: | https://ClinicalTrials.gov/show/NCT02475070/results |
| Conditions: | Type 2 Diabetes |
| Interventions: | DRUG: Vildagliptin|DRUG: Dapagliflozin |
| Outcome Measures: | Primary: Glucagon Response to Meal, Area under the curve (AUC) of the 180 min glucagon levels after mixed meal ingestion (0, 5, 10, 15, 30, 45, 60, 75, 90, 120, 150,180 and 240 minutes post-dose), 240 min | Secondary: Incretin Hormones, Area under the curve (AUC) of the 180 min glucagon like peptide-1 levels after mixed meal (0, 5, 10, 15, 30, 45, 60, 75, 90, 120, 150, 180 and 240 minutes post-dose), 240min |
| Sponsor/Collaborators: | Sponsor: Lund University |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 28 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE |
| Start Date: | 2016-01 |
| Completion Date: | 2017-06 |
| Results First Posted: | 2019-05-02 |
| Last Update Posted: | 2019-05-02 |
| Locations: | Lund University, Lund, 22184, Sweden |
| URL: | https://clinicaltrials.gov/show/NCT02475070 |
